Contineum Therapeutics
CTNM
#7264
Rank
C$0.52 B
Marketcap
$20.33
Share price
4.74%
Change (1 day)
N/A
Change (1 year)

Contineum Therapeutics (CTNM) - Cash on Hand

Cash on Hand as of September 2024 : C$0.30 Billion

According to Contineum Therapeutics's latest financial reports the company has C$0.30 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Contineum Therapeutics - Cash on Hand chart (from 2022 to 2024)

20232024$0.1B$0.15B$0.2B$0.25B$0.3Bcompaniesmarketcap.com

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$0.16 B159.04%
2022-12-31C$64.1 M-27.11%
2021-12-31C$87.94 M